Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS
· Delayed Price · Currency is USD
0.1002
+0.0002 (0.15%)
Mar 28, 2025, 3:57 PM EST
PVCT Revenue
In the year 2024, Provectus Biopharmaceuticals had annual revenue of $617.14K with 10.66% growth. Provectus Biopharmaceuticals had revenue of $14.33K in the quarter ending December 31, 2024, a decrease of -88.17%.
Revenue
617.14K
Revenue Growth
+10.66%
P/S Ratio
68.13
Revenue / Employee
154.29K
Employees
4
Market Cap
43.87M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 16.04M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
American Oncology Network | 1.76B |
Provectus Biopharmaceuticals News
- 2 months ago - Provectus Biopharmaceuticals Announces Seed Financing for VisiRose, Provectus's Spinoff Company for Rose Bengal-Based Eye Drugs - GlobeNewsWire
- 4 months ago - Provectus Biopharmaceuticals, Inc. (PVCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Provectus Biopharmaceuticals GAAP EPS of $0.00, revenue of $0.11M - Seeking Alpha
- 6 months ago - Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call - GlobeNewsWire
- 1 year ago - Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines - GlobeNewsWire
- 1 year ago - Provectus Biopharmaceuticals Announces Acceptance of Cancer Immunotherapy PV-10 Abstract for HNSCC at AACR 2024 Annual Meeting - GlobeNewsWire
- 1 year ago - Provectus Biopharmaceuticals Announces Acceptance of Pharmaceutical-Grade Rose Bengal Sodium Abstract for Poster Presentation at 2024 Society for Investigative Dermatology (SID) Annual Meeting - GlobeNewsWire
- 1 year ago - Provectus Biopharmaceuticals, Inc. (PVCT) Q1 2024 Earnings Call Transcript - Seeking Alpha